The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.15BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
12.79x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Revenue (TTM)
1.93BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
9.02%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Beta
0.6640x
vs all stocks
Updated Jul 19, 2026
52-Week Change
106.72%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
2.15BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
2.41BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing P/E
12.79x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Forward P/E
11.16x
vs Medical Care Facilities peers
Updated Jul 19, 2026
PEG Ratio
0.2603x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Price to Sales (TTM)
1.12x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Price to Book (MRQ)
2.40x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Enterprise to Revenue
1.25x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Enterprise to EBITDA
9.22x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Gross Margin
23.72%
vs Medical Care Facilities peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 26.09%.Updated Jul 19, 2026
Profit Margin
9.02%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Operating Margin
9.78%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Return on Assets (TTM)
7.35%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Return on Equity (TTM)
20.89%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Revenue (TTM)
1.93BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
23.22USDUpdated Jul 19, 2026
Quarterly Revenue Growth
3.90%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Gross Profit (TTM)
504.02MUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
265.49MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
174.22MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
42.60%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Operating Cash Flow (TTM)
258.71MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
163.73MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Jul 19, 2026
Revenue
1.91BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.42BUSDFY2025 · Dec 31, 2025
Gross Profit
493.70MUSDFY2025 · Dec 31, 2025
Operating Income
231.09MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
216.43MUSDFY2025 · Dec 31, 2025
Income Tax Expense
51.04MUSDFY2025 · Dec 31, 2025
Net Income
165.39MUSDFY2025 · Dec 31, 2025
EBIT
252.40MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
256.55MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
240.79MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
35.97MUSDFY2025 · Dec 31, 2025
EPS (Basic)
1.97USDFY2025 · Dec 31, 2025
EPS (Diluted)
1.94USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
84.08MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
84.08MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
165.39MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
270.23MUSDFY2025 · Dec 31, 2025
Free Cash Flow
251.78MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
375.24MUSDFY2025 · Dec 31, 2025
Interest Paid
34.38MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
165.39MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
21.83MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
52.19MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
18.05MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-3.63MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
30.56MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-14.14MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-18.46MUSDFY2025 · Dec 31, 2025
Net Acquisitions
6.80MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-29.85MUSDFY2025 · Dec 31, 2025
Sale of Investments
26.67MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-3.46MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-18.30MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-20.75MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-86.68MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-3.25MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-107.49MUSDFY2025 · Dec 31, 2025
Shares Outstanding
82.06MSharesUpdated Jul 19, 2026
Float Shares
78.85MSharesUpdated Jul 19, 2026
Shares Short
3.80MSharesUpdated Jul 19, 2026
Short Ratio
4.75days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
6.58%
vs all stocks
Updated Jul 19, 2026
% Held by Insiders
2.01%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
106.80%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
328.97MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
4.10USDUpdated Jul 19, 2026
Total Debt (MRQ)
629.72MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
0.7167x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Current Ratio (MRQ)
1.33x
vs Medical Care Facilities peers
Updated Jul 19, 2026
Book Value per Share (MRQ)
10.96USDUpdated Jul 19, 2026
Total Assets
2.25BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
763.51MUSDFY2025 · Dec 31, 2025
Total Liabilities
1.38BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
1.48BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
921.93MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
458.91MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
375.24MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
124.48MUSDFY2025 · Dec 31, 2025
Accounts Receivable
229.66MUSDFY2025 · Dec 31, 2025
Accounts Payable
37.22MUSDFY2025 · Dec 31, 2025
Short-term Debt
38.40MUSDFY2025 · Dec 31, 2025
Long-term Debt
596.22MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
268.69MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
830.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-83.15MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
865.85MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
11.84USDUpdated Jul 19, 2026
52-Week High
27.94USDUpdated Jul 19, 2026
52-Week Change
106.72%
vs all stocks
Updated Jul 19, 2026
Beta
0.6640x
vs all stocks
Updated Jul 19, 2026
50-Day MA
23.76USDUpdated Jul 19, 2026
200-Day MA
21.57USDUpdated Jul 19, 2026
Avg 10-Day Volume
900.91KSharesUpdated Jul 19, 2026
Avg 30-Day Volume
836.92KSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
2.06USDUpdated Jul 19, 2026
Other Income / Expense
21.31MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.27: grey zoneSignificant
Altman Z-Score: 2.27
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $2.15B, above the global median of $1.15BNotable
Market cap (USD): 2,145,845,534Global Median: 1,146,734,693.424
Revenue is $1.93B, above the global median of $520.53MNotable